Spinning a solution in healthcare from a basic technology requires phased research from basic to translational, pre-clinical and clinical studies, for which Japan has a wholesome ecosystem; GN Corp track record, interviewed for a feature story, sponsored by Government of Japan, published in Bloomberg.
neu REFIX enhances Dystrophin and muscle regeneration in mdx mice
1/3/2025
Published in Nature Scientific Reports 01 Mar 2025 neu REFIX® exo-polysaccharide Beta glucan improves Dystroph
